Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Felices

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Prostate Cancer and Prostatic Diseases|February 28, 2024
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient OutcomesNicholas A Zorko, Allison Makovec, Andrew Elliott, et al.
Cancer Immunology Research|November 15, 2024
A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate CancerShee Kwan Phung, Nicholas A Zorko, Yvette Soignier, et al.
Cell Stem Cell|September 15, 2021
Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapyKarrune V Woan, Hansol Kim, Ryan Bjordahl, et al.
Journal for Immunotherapy of Cancer|November 1, 2022
Adaptive single-KIR<sup>+</sup>NKG2C<sup>+</sup> NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemiaAlvaro Haroun-Izquierdo, Marianna Vincenti, Herman Netskar, et al.
Journal for Immunotherapy of Cancer|July 24, 2025
Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancerMelissa J Khaw, Nicholas A Zorko, Philippa R Kennedy, et al.
Cell Reports. Medicine|June 26, 2026
Case of complete response to immunotherapy in MMR-deficient prostate cancer associated with NK-like and CD4<sup>+</sup>CD8<sup>+</sup> T cellsAlexander K Tsai, John R Lozada, Philippa R Kennedy, et al.
Journal for Immunotherapy of Cancer|December 21, 2025
TGF-βRII/IL-15 immunotherapeutic complex targets exhausted CD8<sup>+</sup> T-cell subsets in lymph nodes and tumorsVarghese K George, Hing C Wong, Martin Felices, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Prostate Cancer and Prostatic Diseases|February 28, 2024
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient OutcomesNicholas A Zorko, Allison Makovec, Andrew Elliott, et al.
Cancer Immunology Research|November 15, 2024
A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate CancerShee Kwan Phung, Nicholas A Zorko, Yvette Soignier, et al.
Cell Stem Cell|September 15, 2021
Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapyKarrune V Woan, Hansol Kim, Ryan Bjordahl, et al.
Journal for Immunotherapy of Cancer|November 1, 2022
Adaptive single-KIR<sup>+</sup>NKG2C<sup>+</sup> NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemiaAlvaro Haroun-Izquierdo, Marianna Vincenti, Herman Netskar, et al.
Journal for Immunotherapy of Cancer|July 24, 2025
Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancerMelissa J Khaw, Nicholas A Zorko, Philippa R Kennedy, et al.
Cell Reports. Medicine|June 26, 2026
Case of complete response to immunotherapy in MMR-deficient prostate cancer associated with NK-like and CD4<sup>+</sup>CD8<sup>+</sup> T cellsAlexander K Tsai, John R Lozada, Philippa R Kennedy, et al.
Journal for Immunotherapy of Cancer|December 21, 2025
TGF-βRII/IL-15 immunotherapeutic complex targets exhausted CD8<sup>+</sup> T-cell subsets in lymph nodes and tumorsVarghese K George, Hing C Wong, Martin Felices, et al.
Pageof 8